Notably, the levels of Eotaxin, MCP-1, nerve growth factor (NGF), 8-OHdG, 8-isoprostane, and total antioxidant capacity (TAC) were significantly elevated in IC/BPS patients compared to controls (all p < 0.05). The gene discussed is CCL11; the disease is Bartsocas-Papas syndrome 1.